Gerd Muehllehner Professor and Research Vice Chair, Department of Radiology; Associate Director of Education and Training, Abramson Cancer Center
Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania, United States
Dr. David Mankoff is Gerd Muehllehner Professor of Radiology, Vice-Chair for Research in Radiology, and Director of the PET Center at the Perelman School of Medicine at the University of Pennsylvania. He also serves as the Associate Director for Education and Training for Penn’s Abramson Cancer Center. Dr. Mankoff is board-certified in Nuclear Medicine and holds a PhD in Bioengineering focusing on PET instrumentation. He practices Nuclear Medicine at the University of Pennsylvania, with a special interest in oncologic applications of molecular imaging and radionuclide treatment of endocrine and other cancers. Dr. Mankoff’s research focuses on molecular imaging of cancer, primarily on breast cancer, and emphasizes therapeutic monitoring, identifying factors mediating therapeutic resistance, and the translation of new methods to clinical trials. He also works on imaging methodology and quantitative imaging methods related to molecular cancer imaging. Dr. Mankoff is a Komen Scholar for the Susan G. Komen Foundation. Dr. Mankoff is a past member and President of the American Board of Nuclear Medicine and is on the editorial boards of Nuclear Medicine and Biology, Breast Cancer Research, Journal of Nuclear Medicine, The Breast Journal, and Clinical Cancer Research and serves as an Associate Editor for the Journal of Nuclear Medicine and Breast Cancer Research.
Disclosure: GE Healthcare (Individual(s) Involved: Self): Consultant/Advisory Board; ImaginAb (Individual(s) Involved: Self): Advisory Committee/Board Member, Ownership Interest, SAB, Imaging SAB; Philips Medical (Individual(s) Involved: Self): Consultant/Advisory Board; Reflexion (Individual(s) Involved: Self): Advisory Committee/Board Member, Ownership Interest, SAB; Tervarx (Individual(s) Involved: Both Myself and my Spouse/Partner): Advisory Committee/Board Member, Employment, Ownership Interest, SAB
Sunday, March 14, 2021
1:00 PM – 3:00 PM ET
.png)